114 related articles for article (PubMed ID: 38613909)
21. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.
Nikiteas NI; Tzanakis N; Gazouli M; Rallis G; Daniilidis K; Theodoropoulos G; Kostakis A; Peros G
World J Gastroenterol; 2005 Mar; 11(11):1639-43. PubMed ID: 15786541
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
[TBL] [Abstract][Full Text] [Related]
23. Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group.
Nielsen HJ; Christensen IJ; Sørensen S; Moesgaard F; Brünner N
Ann Surg Oncol; 2000 Sep; 7(8):617-23. PubMed ID: 11005561
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of the postoperative ratio of C-reactive protein to albumin for complications after colorectal surgery.
Ge X; Cao Y; Wang H; Ding C; Tian H; Zhang X; Gong J; Zhu W; Li N
World J Surg Oncol; 2017 Jan; 15(1):15. PubMed ID: 28069031
[TBL] [Abstract][Full Text] [Related]
25. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
26. Postoperative Serum C-Reactive Protein Level Predicts Long-Term Outcomes in Colorectal Cancer Patients.
Aoki S; Migita K; Ueno M; Yasuda S; Fujimoto K; Doi S; Ishikawa H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2113-2116. PubMed ID: 33468878
[TBL] [Abstract][Full Text] [Related]
27. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases.
Li C; Xu Q; Chen L; Luo C; Ying J; Liu J
Bull Cancer; 2017 Mar; 104(3):232-236. PubMed ID: 28063672
[TBL] [Abstract][Full Text] [Related]
28. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
Cao X; Yu T; Zhao G; Xiao G
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
[TBL] [Abstract][Full Text] [Related]
29. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
30. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
[TBL] [Abstract][Full Text] [Related]
33. Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma.
Nozoe T; Mori E; Takahashi I; Ezaki T
Surg Today; 2008; 38(7):597-602. PubMed ID: 18612783
[TBL] [Abstract][Full Text] [Related]
34. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
[TBL] [Abstract][Full Text] [Related]
35. Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.
Sim SH; Messenger MP; Gregory WM; Wind TC; Vasudev NS; Cartledge J; Thompson D; Selby PJ; Banks RE
Br J Cancer; 2012 Sep; 107(7):1131-7. PubMed ID: 22918393
[TBL] [Abstract][Full Text] [Related]
36. Combination of C-reactive Protein and Monocyte Count Is a Useful Prognostic Indicator for Patients With Colorectal Cancer.
Yamamoto M; Saito H; Hara K; Sugezawa K; Uejima C; Tanio A; Tada Y; Kihara K; Sakamoto T; Honjo S; Fujiwara Y
In Vivo; 2020; 34(1):299-305. PubMed ID: 31882492
[TBL] [Abstract][Full Text] [Related]
37. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
[TBL] [Abstract][Full Text] [Related]
38. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
[TBL] [Abstract][Full Text] [Related]
39. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
[TBL] [Abstract][Full Text] [Related]
40. Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.
Steffens S; Köhler A; Rudolph R; Eggers H; Seidel C; Janssen M; Wegener G; Schrader M; Kuczyk MA; Schrader AJ
BMC Cancer; 2012 Sep; 12():399. PubMed ID: 22958305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]